801184531	801184531	CD	B-NP	O
|	|	NN	I-NP	O
MMH	MMH	NN	I-NP	O
|	|	NN	I-NP	O
70813901	70813901	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
719791	719791	CD	B-NP	O
|	|	CC	I-NP	O
11/23/2000	11/23/2000	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
UNSTABLE	UNSTABLE	NNP	I-NP	I-protein
ANGINA	ANGINA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/23/2000	9/23/2000	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/3/2000	6/3/2000	CD	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
MYOCARDIAL	MYOCARDIAL	JJ	B-NP	O
INFARCTION	INFARCTION	NN	I-NP	O
AND	AND	CC	I-NP	O
VENTRICULAR	VENTRICULAR	NN	I-NP	O
TACHYCARDIA	TACHYCARDIA	NN	I-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

DIABETES	DIABETES	NNS	B-NP	O
MELLITUS	MELLITUS	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

HYPERCHOLESTEROLEMIA	HYPERCHOLESTEROLEMIA	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Dersch	Dersch	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
75	75	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	B-protein
infarction	infarction	NN	I-NP	I-protein
x2	x2	NN	I-NP	I-protein
,	,	,	O	O
status	status	NN	B-NP	B-protein
post	post	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
x3	x3	NN	I-NP	I-protein
in	in	IN	B-PP	O
1993	1993	CD	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
event	event	NN	I-NP	O
of	of	IN	B-PP	O
stable	stable	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
coronary	coronary	JJ	I-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
include	include	VBP	B-VP	O
age	age	NN	B-NP	O
,	,	,	O	O
male	male	JJ	B-NP	O
gender	gender	NN	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
or	or	CC	I-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
actually	actually	RB	B-ADVP	O
began	begin	VBD	B-VP	O
in	in	IN	B-PP	O
1988	1988	CD	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
ruled	rule	VBN	B-VP	O
in	in	IN	B-PP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
anteroseptal	anteroseptal	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
9/16	9/16	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
with	with	IN	B-PP	O
wide	wide	JJ	B-NP	O
complex	complex	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
requiring	require	VBG	B-VP	O
electrical	electrical	JJ	B-NP	O
cardioversion	cardioversion	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Joadi	Joadi	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
in	in	IN	B-PP	O
1998	1998	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
proximal	proximal	JJ	B-NP	O
LAD	LAD	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
,	,	,	O	O
an	an	DT	O	O
occluded	occlude	VBD	B-VP	O
proximal	proximal	JJ	B-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
off	off	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
hemodynamics	hemodynamic	NNS	I-NP	O
,	,	,	O	O
anteroseptal	anteroseptal	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
inferior	inferior	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
apical	apical	JJ	B-NP	O
thrombus	thrombus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
aneurysm	aneurysm	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
EP	EP	NN	I-NP	O
study	study	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
27	27	CD	B-NP	O
and	and	CC	I-NP	O
22	22	CD	I-NP	O
beat	beat	JJ	I-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
nonsustained	nonsustained	JJ	B-NP	O
V-tach	V-tach	NN	I-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
inducible	inducible	JJ	B-ADJP	O
after	after	IN	B-PP	O
three	three	CD	B-NP	O
ventricular	ventricular	JJ	I-NP	O
extra	extra	JJ	I-NP	O
stimuli	stimulus	NNS	I-NP	O
during	during	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
drive	drive	NN	I-NP	O
pacing	pacing	NN	I-NP	O
at	at	IN	B-PP	O
400	400	CD	B-NP	O
msec	msec	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
suppressed	suppress	VBN	I-VP	O
with	with	IN	B-PP	O
quinidine	quinidine	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
subsequently	subsequently	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
quinidine	quinidine	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
aconine	aconine	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
until	until	IN	B-PP	O
3/13	3/13	CD	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
orthopnea	orthopnea	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
1/16	1/16	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
failed	fail	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
fatigue	fatigue	VB	I-VP	O
.	.	.	O	O

During	During	IN	B-PP	O
this	this	DT	B-NP	O
ETT	ETT	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
actually	actually	RB	B-ADVP	O
fell	fall	VBD	B-VP	O
from	from	IN	B-PP	O
125	125	CD	B-NP	O
to	to	TO	B-PP	O
85	85	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
revealed	reveal	VBD	B-VP	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depression	depression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
limb	limb	NN	I-NP	O
leads	lead	VBZ	B-VP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
8/5/93	8/5/93	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Eredrens	Eredrens	NNP	I-NP	O
Recraw	Recraw	NNP	I-NP	O
University	University	NNP	I-NP	O
Of	Of	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
LAD	LAD	NN	I-NP	O
and	and	CC	I-NP	O
RCA	RCA	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
,	,	,	O	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
ramus	ramus	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
left	left	JJ	B-NP	O
ventriculogram	ventriculogram	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
anterior	anterior	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
inferior	inferior	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
apical	apical	JJ	B-NP	O
dyskinesis	dyskinesis	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
48	48	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
made	make	VBN	I-VP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
1/16	1/16	CD	I-NP	O
admission	admission	NN	I-NP	O
to	to	TO	B-VP	O
proceed	proceed	VB	I-VP	O
with	with	IN	B-PP	O
surgical	surgical	JJ	B-NP	O
revascularization	revascularization	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
three	three	CD	I-NP	O
vessel	vessel	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
with	with	IN	B-PP	O
LIMA	LIMA	NN	B-NP	B-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
and	and	CC	O	O
proximal	proximal	JJ	B-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
endarterectomy	endarterectomy	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
EP	EP	NN	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
sustained	sustained	JJ	I-NP	O
ventricular	ventricular	NN	I-NP	O
was	be	VBD	B-VP	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
inducible	inducible	JJ	B-ADJP	O
either	either	CC	O	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
or	or	CC	B-PP	O
during	during	IN	B-PP	O
isoproterenol	isoproterenol	NN	B-NP	O
infusion	infusion	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
1993	1993	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
doing	do	VBG	I-VP	O
well	well	RB	B-ADVP	O
up	up	IN	B-PP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
on	on	IN	B-PP	O
3/1	3/1	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
light-headedness	light-headedness	NN	B-NP	O
and	and	CC	I-NP	O
palpitations	palpitation	NNS	I-NP	O
while	while	IN	B-SBAR	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
toilet	toilet	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	I-NP	O
nausea	nausea	NN	I-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

EMS	EMS	NNS	B-NP	O
was	be	VBD	B-VP	O
notified	notify	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
V-tach	V-tach	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
and	and	CC	O	O
cardioverted	cardioverte	VBD	B-VP	O
at	at	IN	B-PP	O
100	100	CD	B-NP	O
joules	joule	NNS	I-NP	O
after	after	IN	B-PP	O
failing	fail	VBG	B-VP	O
attempted	attempted	JJ	B-NP	O
pharmacologic	pharmacologic	JJ	I-NP	O
conversion	conversion	NN	I-NP	O
with	with	IN	B-PP	O
Lidocaine	Lidocaine	NN	B-NP	O
,	,	,	O	O
adenosine	adenosine	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
amiodarone	amiodarone	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Villecam	Villecam	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
and	and	CC	O	O
possible	possible	JJ	B-NP	O
placement	placement	NN	I-NP	O
of	of	IN	B-PP	O
AICD	AICD	NN	B-NP	B-protein
.	.	.	O	O

On	On	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
complaints	complaint	NNS	B-NP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	B-protein
lower	low	JJR	I-NP	I-protein
abdominal	abdominal	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
attributed	attribute	VBN	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
known	known	JJ	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-ADVP	O
above	above	RB	I-ADVP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
CABG	CABG	NN	B-NP	O
in	in	IN	B-PP	O
1993	1993	CD	B-NP	O
,	,	,	O	O
details	detail	VBZ	B-VP	O
noted	note	VBN	I-VP	O
above	above	IN	B-PP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
,	,	,	O	O
alcohol	alcohol	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
drugs	drug	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	I-VP	O
retired	retire	VBN	I-VP	O
and	and	CC	O	O
living	live	VBG	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Lipitor	Lipitor	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
;	;	:	O	O
metoprolol	metoprolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
Cytotec	Cytotec	NN	B-NP	O
200	200	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
;	;	:	O	O
glipizide	glipizide	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
Glucophage	Glucophage	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NNS	I-NP	O
:	:	:	O	O
Temp	Temp	NN	B-NP	B-protein
97.5	97.5	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
63	63	CD	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
140/80	140/80	CD	I-NP	I-DNA
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
16-18	16-18	NN	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
pleasant	pleasant	JJ	I-NP	O
male	male	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
sitting	sit	VBG	I-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEART	HEART	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
I/VI	I/VI	NN	I-NP	B-protein
systolic	systolic	JJ	I-NP	I-protein
ejection	ejection	NN	I-NP	I-protein
murmur	murmur	NN	I-NP	I-protein
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
air	air	NN	I-NP	O
movement	movement	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
non-tender	non-tender	JJ	I-NP	O
,	,	,	I-NP	O
non-distended	non-distended	JJ	I-NP	O
,	,	,	I-NP	O
positive	positive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	O	O
cyanosis	cyanosis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
noted	note	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
No	No	DT	B-NP	O
focal	focal	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Glucose	Glucose	NN	B-NP	B-protein
130	130	CD	I-NP	I-protein
,	,	,	O	O
Na	Na	NNP	B-NP	O
139	139	CD	I-NP	O
,	,	,	O	O
K	K	NN	B-NP	B-cell_line
4.7	4.7	NN	I-NP	I-cell_line
,	,	,	O	O
Cl	Cl	NN	B-NP	B-protein
107	107	CD	I-NP	I-protein
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
26	26	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NNP	B-NP	O
15	15	CD	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.1	1.1	CD	I-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
364	364	CD	I-NP	I-protein
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
MB	MB	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
43.9	43.9	CD	B-NP	O
.	.	.	O	O

T.	T.	NN	B-NP	O
protein	protein	NN	I-NP	O
6.7	6.7	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	B-protein
4.0	4.0	CD	I-NP	I-protein
,	,	,	O	O
Ca	Ca	NNP	B-NP	O
9.4	9.4	CD	I-NP	O
,	,	,	O	O
mag	mag	NN	B-NP	O
1.8	1.8	CD	I-NP	O
.	.	.	O	O

Cholesterol	Cholesterol	NN	B-NP	B-protein
187	187	CD	I-NP	I-protein
,	,	,	O	O
triglycerides	triglyceride	NNS	B-NP	O
468	468	CD	B-NP	O
,	,	,	O	O
HDL	HDL	NN	B-NP	B-DNA
28	28	CD	I-NP	I-DNA
,	,	,	O	O
LDL	LDL	NN	B-NP	O
96	96	CD	I-NP	O
.	.	.	O	O

Dig	Dig	NNP	B-NP	O
level	level	NN	I-NP	O
1.1	1.1	CD	I-NP	O
,	,	,	O	O
troponin-I	troponin-I	NN	B-NP	O
6.95	6.95	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
count	count	NN	I-NP	O
10.09	10.09	CD	I-NP	O
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
13.6	13.6	CD	I-NP	I-protein
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
38.2	38.2	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
232	232	CD	B-NP	O
.	.	.	O	O

Differential	Differential	NNP	B-NP	O
revealed	reveal	VBD	B-VP	O
19.7	19.7	CD	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
,	,	,	O	O
5.2	5.2	CD	B-NP	O
monocytes	monocyte	NNS	I-NP	B-cell_type
,	,	,	O	O
74	74	CD	B-NP	O
neutrophils	neutrophil	NNS	I-NP	B-cell_type
.	.	.	O	O

PT	PT	NN	B-NP	B-protein
11.9	11.9	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
25.7	25.7	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.0	1.0	CD	I-NP	I-protein
.	.	.	O	O

UA	UA	NN	B-NP	O
-	-	HYPH	O	O
Color	Color	NN	B-NP	O
was	be	VBD	B-VP	O
yellow	yellow	JJ	B-NP	O
,	,	,	I-NP	O
specific	specific	JJ	I-NP	O
gravity	gravity	NN	I-NP	O
1.011	1.011	CD	I-NP	O
,	,	,	O	O
pH	pH	NN	B-NP	O
6.0	6.0	CD	I-NP	O
,	,	,	O	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
protein	protein	NN	B-NP	O
,	,	,	O	O
ketones	ketone	NNS	B-NP	O
,	,	,	O	O
bilis	bilis	NN	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
,	,	,	O	O
leukocyte	leukocyte	NN	B-NP	B-protein
esterase	esterase	NN	I-NP	I-protein
,	,	,	O	O
or	or	CC	O	O
nitrites	nitrite	NNS	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
glucose	glucose	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
for	for	IN	B-PP	O
WBCs	WBC	NNS	B-NP	B-cell_type
,	,	,	O	O
RBCs	RBC	NNS	B-NP	B-cell_type
,	,	,	O	O
bacteria	bacteria	NNS	B-NP	O
,	,	,	O	O
casts	cast	NNS	B-NP	O
,	,	,	O	O
squamous	squamous	JJ	B-NP	O
epithelials	epithelial	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
crystals	crystal	NNS	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
since	since	IN	B-PP	O
his	his	PRP$	B-NP	O
transfer	transfer	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
notable	notable	JJ	B-NP	O
persistent	persistent	JJ	I-NP	O
native	native	JJ	I-NP	O
vessel	vessel	NN	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
patent	patent	NN	B-NP	B-protein
bypass	bypass	IN	B-PP	I-protein
graft	graft	NN	B-NP	I-protein
x3	x3	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
captopril	captopril	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
eventually	eventually	RB	I-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
AICD	AICD	NN	I-NP	O
placed	place	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
EP	EP	NN	I-NP	O
service	service	NN	I-NP	O
with	with	IN	B-PP	O
pacer	pacer	NN	B-NP	O
leads	lead	VBZ	B-VP	O
confirmed	confirm	VBN	I-VP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
position	position	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
experience	experience	NN	B-NP	O
one	one	CD	B-NP	O
approximately	approximately	RB	I-NP	O
10	10	CD	I-NP	O
beat	beat	JJ	I-NP	O
run	run	NN	I-NP	O
of	of	IN	B-PP	O
V-tach	V-tach	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
trigger	trigger	VB	I-VP	O
the	the	DT	B-NP	O
AICD	AICD	NNP	I-NP	O
to	to	TO	B-VP	O
fire	fire	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
experience	experience	VB	I-VP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
lower	low	JJR	I-NP	O
abdominal	abdominal	JJ	I-NP	O
and	and	CC	I-NP	O
low	low	JJ	I-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
with	with	IN	B-PP	O
Ultram	Ultram	NN	B-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
had	have	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
better	good	JJR	B-NP	O
p.o.	p.o.	NN	I-NP	O
and	and	CC	I-NP	O
ambulate	ambulate	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Vitamin	Vitamin	NN	B-NP	O
C	C	NN	I-NP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
Ecotrin	Ecotrin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
captopril	captopril	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
Digoxin	Digoxin	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
glipizide	glipizide	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
metoprolol	metoprolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
Cytotec	Cytotec	NN	B-NP	O
200	200	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
;	;	:	O	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
SL	SL	NN	I-NP	I-protein
1/150	1/150	CD	I-NP	I-protein
1	1	CD	I-NP	I-protein
tab	tab	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
5	5	CD	B-NP	I-protein
minutes	minute	NNS	I-NP	I-protein
x3	x3	CD	B-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
;	;	:	O	O
Vitamin	Vitamin	NN	B-NP	O
E	E	NN	I-NP	O
400	400	CD	I-NP	O
U	U	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Keflex	Keflex	NNP	B-NP	O
250	250	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
x3	x3	NN	I-NP	O
days	day	NNS	I-NP	O
;	;	:	O	O
Ultram	Ultram	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
;	;	:	O	O
Lipitor	Lipitor	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
;	;	:	O	O
Glucophage	Glucophage	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Low	Low	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
saturated	saturate	VBN	I-NP	O
fat	fat	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

Return	Return	NN	B-NP	O
to	to	TO	B-VP	O
work	work	VB	I-VP	O
not	not	RB	O	O
applicable	applicable	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
FOLLOW-UP	FOLLOW-UP	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Jose	Jose	NNP	I-NP	O
Goodstein	Goodstein	NNP	I-NP	O
,	,	,	O	O
cardiologist	cardiologist	NN	B-NP	O
at	at	IN	B-PP	O
EP	EP	NNP	B-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
7/27	7/27	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
make	make	VB	I-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
within	within	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
HASSAN	HASSAN	NNP	B-NP	O
LIBBY	LIBBY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
PA356	PA356	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CHARLES	CHARLES	NNP	B-NP	O
M.	M.	NNP	I-NP	O
DEVEREAUX	DEVEREAUX	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
OV9	OV9	NNP	I-NP	O
KS301/0223	KS301/0223	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
15927	15927	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

FLHK1Z2HHJ	FLHK1Z2HHJ	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
11/15	11/15	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
11/2	11/2	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

TODD	TODD	NNP	B-NP	O
V.	V.	NNP	I-NP	O
OLIVID	OLIVID	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
JZ2	JZ2	NNP	I-NP	O

